You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3

Citation Tools

Article menu

This article has a correction. Please see:

Basic tumor immunology
Original research
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ao Y, Gao J, Jin C, et al
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
Journal for ImmunoTherapy of Cancer 2023;11:e007766. doi: 10.1136/jitc-2023-007766